Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030305 (
pancreatitis
)
16,014
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The diagnosis of both acute and chronic pancreatitis continues to be a challenge despite the development of new techniques and the refinement of old methods. The problem is best approached by the application of a combination of tests which can provide a reasonable degree of sensitivity and specificity applicable to the different forms of
pancreatitis
. In acute pancreatitis an elevation of serum amylase and amylase/creatinine clearance ratio is diagnostically useful. In chronic pancreatitis, several tests are needed to enhance the diagnostic yield, and such tests can include the secretin-pancreozymin test, ERCP, fecal fat measurement, Lundh test meal, and the administration of the synthetic peptide BZ-Ty-
PABA
.
...
PMID:Laboratory aids in the diagnosis of pancreatitis. 34 Aug 13
The oral (
PABA
) pancreatic function test (PFT), the secretin-pancreozymin test and endoscopic retrograde pancreatography (ERCP) have been carried out in 32 patients with suspected chronic alcohol induced
pancreatitis
(CAIP) in order to evaluate which, if any, test was most likely to confirm the provisional diagnosis. Thirty one patients had changes of minimal (n = 6) moderate (n = 7) or advanced (n = 18) chronic pancreatitis on pancreatography, whilst one patient had a pancreas divisum. Eight hour urinary
PABA
excretion was significantly reduced in patients with moderate and advanced structural changes (p less than 0.001) and correlated significantly with all parameters of the PFT, although eight patients with an abnormal pancreatogram and pancreatic function test had a normal
PABA
value. The PFT was abnormal in 23 patients, but normal in five patients with an abnormal pancreatogram and low
PABA
value. Most patients with minimal change
pancreatitis
had a normal
PABA
test and PFT. We conclude that pancreatography appears to be the most sensitive method for detecting chronic pancreatic damage and for confirming a clinical diagnosis of chronic alcohol induced
pancreatitis
. Both the PFT and
PABA
test are useful confirmatory tests and whilst the PFT is slightly more sensitive for assessing pancreatic exocrine function, the
PABA
test is well tolerated and simple to perform. It may therefore be the complementary investigation of choice for this group of patients.
...
PMID:Comparison of the oral (PABA) pancreatic function test, the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis. 387 66
In many ways diagnosis of pancreatic disorders in children is difficult. Since pancreatic parameters are age-dependent, reliable laboratory parameters are not easily established. Children are less likely than adults to endure tolerance tests and invasive test methods should therefore be used only in special situations. Estimation of chymotrypsin in faeces seems to be an earlier indicator of pancreatic insufficiency than the
PABA
-peptide-test. A secretin-pancreozymin test can only be advised for first diagnosis after screening has repeatedly indicated pathological values and malabsorption has more or less been ruled out. A threefold rise in serum amylase values - matched for age - suggests
pancreatitis
and sonography should then be applied to obtain further clarification.
...
PMID:[Diagnosis of pancreatic diseases in childhood (author's transl)]. 616 3
Eleven healthy volunteers (C) and nine patients affected by chronic relapsing
pancreatitis
(CP) were administered N-Benzoyl-L-Tyrosyl-
PABA
orally, at a dose of 150 mg combined, on different days, with: 1) water alone (schedule a); 2) Lundh meal (schedule b); 3) Secretin-Caerulein by i.v. infusion (0.5 CU/kg/hr and 75 ng/kg/hr respectively) (schedule c); 4) Caerulein by i.m. injection (300 ng/kg) (schedule d). The mean urinary
PABA
recovery in CP was lower than in C with all the schedules, but this was statistically significant only with schedules a and c (P less than 0.02 and P less than 0.05 respectively). With respect to b, c, and d, the mean urinary
PABA
recovery seemed to increase both in C and in CP as compared with schedule a, but only in the CP group with schedule b was the increase statistically significant (P less than 0.05). The present data show that the exocrine pancreatic stimulants do not improve the reliability of the
PABA
test.
...
PMID:Urinary PABA recovery after oral N-benzoyl-L-tyrosyl-PABA administration combined with various exocrine pancreatic stimulants. 697 Jan 60
The PFD test was performed on various pancreatic disease patients. The urinary
PABA
excretion rate was significantly lower in chronic pancreatitis patients and in pancreatic carcinoma patients than in the controls, but no difference was observed between
PABA
excretion in the two diseases. After surgery,
PABA
excretion values of pancreatic carcinoma patients were significantly lower than those of non-
pancreatitis
non-pancreatic carcinoma patients. This was thought to be caused by the difference in residual anastomosed pancreatic tissues. Mild to severe
pancreatitis
, fibrosis and/or fat necrosis were seen in the pancreatic tissues of carcinoma patients, but these changes were minimal in non-
pancreatitis
non-pancreatic carcinoma patients. The PFD test is useful in detecting decreases in pancreatic exocrine functions or measuring the grade of pancreatic disorders in various pancreatic diseases, although it can not be used to differentiate pancreatic diseases.
...
PMID:The PFD test for pancreatic disease patients. 697 9
The comparative sensitivity of 4 tubeless pancreatic function tests was evaluated in 125 patients with proved chronic pancreatitis associated with various degrees of pancreatic insufficiency. NBT-
PABA
, immunoreactive trypsin (IRT), and pancreatic isoamylase (P-iso) were studied in relation to the fecal chymotrypsin test (FCT) and steatorrhea. In advanced insufficiency (steatorrhea or FCT less than 20 micrograms/g)
PABA
, IRT, and P-iso were pathologically low in only 70-85% of patients. In less severe pancreatic insufficiency (FCT 21-120 micrograms/g) these tests yielded pathological results in 35-53% of patients. Thus the sensitivity of the three tests was comparable and rather low. IRT values (and P-iso) were constantly low or progressively decreasing in 64% of patients (30/47) studied repeatedly over an average of 17 months. The serum enzyme tests seem, therefore, to be valuable for monitoring pancreatic insufficiency, like the FCT. This is particularly important for the differential diagnosis of acute (reversible) and chronic (progressive)
pancreatitis
.
...
PMID:Comparative diagnostic accuracy of four tubeless pancreatic function tests in chronic pancreatitis. 698 71
The useful laboratory tests in the
pancreatitis
study are revised. A short description of the procedures, its sensibility and specificity, availability and indication is made. In acute pancreatitis the different enzymatic determinations in serum and urine that are used to establish the illness diagnosis and prognosis are described and also, the results of other substances assays like some acute phase reactants that can be useful as prognostic factors. In chronic pancreatitis the different levels in which pancreatic insufficiency can be studied are described as well as the test that can be done in each case. The complexity, specificity and sensibility of direct tests is analyzed. Nevertheless functional exploration methods that constitute a useful alternative as pancreolaurly,
PABA
or the recently proposed plasmatic amino acids and marked triglicerids with C13 are also mentioned. The clinical laboratory in the diagnosis of
pancreatitis
is complementary to the image methods and it is considered indispensable to perform at least two precise methods and it is considered indispensable to perform at least two precise methods of enzymatic determination in serum and an indirect test or another non invasive test that should be validated in each group for the study of gastroenterologic patients.
...
PMID:[The clinical laboratory in the study of pancreatitis]. 774 23
Sixty-five patients with neoplasm (62 cases) or
pancreatitis
(3 cases) were treated with preserving pylorus pancreatoduodenectomy (PPPD) from 1984 to 1991. One postoperative death occurred. Follow-up studies were performed in 35 patients who had been treated by PPPD or the standard Whipple's procedure; they were questioned carefully concerning clinical symptoms. Further studies were performed in 20 patients with or without pylorus preservation (10 patients, respectively). Nutritional status and gastrointestinal digestive and absorptive functions were evaluated by determination of serum components, gastric analysis, barium emptying time, D-xylose absorption test, 14CO2 breath test,
PABA
, and other methods. The results demonstrated malnutrition and postgastrectomy syndromes in some patients after the standard Whipple's procedure, but not in those with PPPD. The quality of life was better in the latter. Pylorus preservation may be the main reason for this above difference. Delayed gastric emptying in the early postoperative period was a complication in some patients (21%) treated by PPPD. We recommend PPPD for pancreatoduodenectomy.
...
PMID:65 cases of preserving pylorus pancreatoduodenectomy: experience and problems. 786 38